Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Incyte Corp (INCY)

66.56 -0.23 (-0.34%)

05-22 16:00

Open:

67.14

Pre. Close:

66.79

High:

67.52

Low:

66.39

Volume:

903,343

Market Cap:

14109M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

67.65 - 68.034

68.034 - 68.452

Low:

65.306 - 65.734

65.734 - 66.199

Close:

65.755 - 66.497

66.497 - 67.303

Technical analysis  (as of: 2018-05-22 4:40:06 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 83.14     One year: 97.11

Support:

Support1: 64.41    Support2: 60.23

Resistance:

Resistance1: 71.18    Resistance2: 83.14

Pivot:

65.11

Moving Averages:

MA(5): 66.97     MA(20): 64.40

MA(100): 81.90     MA(250): 103.41

MACD:

MACD(12,26): -1.10     Signal(12,26,9): -2.09

%K %D:

%K(14,3): 85.71     %D(3): 87.64

RSI:

RSI(14): 46.59

52-Week:

High: 140.11  Low: 60.23  Change(%): -51.8

Average Vol(K):

3-Month: 265532  10-Days 198536

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
INCY has closed below upper band by 33.5%. Bollinger Bands are 34.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-15T08:28:41-04:00
Biotechs Emerge Unscathed And Ready To Go!

2018-05-14T11:37:23-04:00
JF's Core Biotech Buys #15: Removal Of A Key Overhang, Buying Weakness In I-O, Updates And Adding To 2 Positions

2018-05-04T03:45:38-04:00
Rounds Report: Exelixis Rallied Due To Positive Earnings While Achaogen Is Set For A Strong Comeback

2018-05-03T05:26:56-04:00
IDO Appears To Have Wiped Out

2018-05-01T13:55:52-04:00
Incyte (INCY) Q1 2018 Results - Earnings Call Transcript

2018-05-01T10:04:54-04:00
Developers backing away from IDO inhibitors after Incyte's epacadostat flop

2018-05-01T09:32:57-04:00
Incyte Corporation 2018 Q1 - Results - Earnings Call Slides

2018-05-01T08:40:07-04:00
Incyte Q1 top line up 30%, Jakafi sales up 25%; shares down 3% premarket on consensus miss

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

211.97

Shares Float (M)

209.26

% Held by Insiders

1.30

% Held by Institutions

95.10

Shares Short (K)

6871

Shares Short Prior Month (K)

5980

Stock Financials

EPS

-0.050

EPS Est. Current Year

-0.810

EPS Est. Next Year

0.420

EPS Est. Next Quarter

0.100

Forward EPS

1.670

Book Value (p.s.)

8.500

PEG Ratio

3.48

Profit Margin

-10.90

Operating Margin

-10.33

Return on Assets (ttm)

-8.6

Return on Equity (ttm)

-12.9

Qtrly Rev. Growth

-0.5

Gross Profit (p.s.)

5.130

Sales Per Share

EBITDA (p.s.)

-0.359

Qtrly Earnings Growth

Operating Cash Flow (M)

101.49

Levered Free Cash Flow (M)

67.52

atoplab.com

Valuation

P/E

-1331.20

P/E Growth Ratio

P/BV

7.83

P/S

1919554176.00

P/CF

139.02

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.